在帕金森病和健康成年人的双手协调和神经肌肉同步
Madison Weinrich1, Osmar P Neto2,3, Yiyu Wang4
1Department of Kinesiology and Sport Management, Texas A&M University, College Station, TX, 77843-4243, USA.
Experimental brain research
|April 1, 2025
概括
帕金森病会损害力生产的平滑性和对称性,而不是基本的时间,因为神经同步被破坏. 这影响了帕金森病 (PD) 患者的双人协调.
科学领域:
- 神经科学是一个神经科学.
- 发动机控制器的控制器
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 显著损害运动功能,影响美国超过150万人.
- 患PD的特点是运动速度,力计时和力调节的缺陷,影响功能独立性.
- 这项研究调查了PD对双手协调的影响,重点关注时间准确性,力产生和神经肌肉同步.
研究的目的:
- 为了比较患有PD的个体,健康的老年人 (HOA) 和健康的年轻人 (HYA) 的双月协调参数.
- 在稳定的力量协调任务中评估时间准确性,力量产生和神经肌肉同步.
- 阐明神经同步和PD中的力量生产缺陷之间的关系.
主要方法:
- 参与者:13名患有PD的个人,13名HOA和15名HYA.
- 任务:1:1在相 (0°) 双手同度力协调任务使用食指.
- 测量:第一个脊椎骨间肌肉的电肌图 (EMG),力产生指标 (和性,不对称性) 和神经肌肉同步 (力-力和EMG-EMG一致性).
主要成果:
- 所有组都显示出可比的时间准确性和稳定性 (频率比,绝对误差,可变性).
- 与HOA和HYA组相比,PD组表现出明显较低的力和性和更大的力不对称性.
- 在PD组中观察到力量-力连贯性降低和EMG-EMG同步性降低 (α频段),特别是在更高的频率下.
结论:
- 虽然基本的时协调得到保留,但帕金森病会损害力生产的平滑性和对称性.
- 神经同步中断是PD中这些力量生产缺陷的潜在机制.
- 研究结果强调了神经驱动协调在运动控制中的关键作用,并提出了康复策略的目标.
相关概念视频
Parkinson's Disease: Treatment
162
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
162
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Parkinson's Disease: Overview
353
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
353


